Cost Analysis and Outcomes of Endoscopic, Minimal Access and Open Pancreatic Necrosectomy. Issue 2 (7th June 2021)

• Record Type: Journal Article
• Authors: Saunders, Rebecca; Hughes, Faye E.; Evans, Jonathan C.; Smart, Howard L.; Ghaneh, Paula; Ramesh, Jayapal; Sutton, Robert; Halloran, Christopher M.
• Is Part Of: Annals of surgery open. Volume 2:Issue 2(2021)
• Page Start: e068
• Publication Date: 2021-06-07
• Subjects: Surgery -- Periodicals; Surgery -- History -- Periodicals; General Surgery; Surgery; History; Periodicals; 616
• DOI: 10.1097/AS9.0000000000000068
• Languages: English
• ISSNs: 2691-3593

Abstract

Abstract : Objectives: To assess both individual patient and institutional costs as well as outcomes in patients with pancreatic necrosis who underwent either endoscopic, minimal access or open pancreatic necrosectomy. These data can be used to evaluate clinical effectiveness with a view to informing local healthcare providers. Background: Intervention for infected pancreatic necrosis is associated with a high morbidity, mortality, and long hospital stays. Minimal access surgical step-up approaches have been the gold standard of care; however, endoscopic approaches are now offered preferentially. Methods: All patients undergoing endoscopic (EN), minimal access retroperitoneal (MARPN), and open (OPN) necrosectomy at a single institution from April 2015 to March 2017 were included. Patients were selected for intervention based on morphology and position of the necrosis and on clinical factors. Patient-level costing systems were used to determine inpatient and outpatient costs. Results: Eighty-six patients were included: 38 underwent EN, 35 MARPN, and 13 OPN. Preoperative APACHEII was 6 versus 9 versus 9 ( P = 0.017) and CRP 107 versus 204 versus 278 ( P = 0.012), respectively. Postoperative stay was 19 days for EN versus 41 for MARPN versus 42 for OPN ( P = 0.007). Complications occurred in 68.4%, 68.6%, and 46.2% ( P = 0.298), whereas mortality was 10.5%, 22.9%, and 15.4% ( P = 0.379), respectively. Mean total cost was £31, 364 for EN, £52, 770 for MARPN ( P = 0.008), and £60, 346 for OPN. Ward and critical care costs for EN were lower than for MARPN (ward: £9430 vs £14, 033, P = 0.024; critical care: £5317 vs £16, 648, P = 0.056). Conclusions: EN was at least as safe and effective as MARPN and OPN and was associated with markedly reduced hospital stay and cost, although some markers of disease severity were higher in patients undergoing MARPN and OPN. These results support EN as the preferred approach to necrosectomy, but hybrid utilization of all available techniques remains integral to optimal outcomes. Abstract : Mini Abstract A comparison of healthcare costs and clinical outcomes was performed for 86 patients undergoing intervention for pancreatic necrosectomy. Postoperative hospital stay was reduced following endoscopic necrosectomy compared to minimal access or open necrosectomy. Total healthcare costs were reduced for patients treated by endoscopic necrosectomy. Supplemental Digital Content is available in the text.